While we have not elucidated the precise underlying mechanism for why IDH-mutant-expressing gliomas show an enhanced response to HDAC inhibition, we did find a more vigorous apoptotic response after treatment with an HDACi such as belinostat in the glioma cells engineered to express mtIDH1. Here, IDH2 is linked to glioma.